Gemmer Asset Management LLC Eli Lilly & CO Transaction History

Gemmer Asset Management LLC

$922 Million
Q2 2024

A detailed history of Gemmer Asset Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Gemmer Asset Management LLC holds 1,047 shares of LLY stock, worth $964,800. This represents 0.1% of its overall portfolio holdings.

Number of Shares

1,047

Previous 1,024 2.25%

Holding current value

$964,800

Previous $796,000 18.97%

% of portfolio

0.1%

Previous 0.09%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	BUY	$724.87 - $909.04 $16,672 - $20,907	23 Added 2.25%	1,047 $947,000
Q4 2023 Jan 17, 2024	SELL	$525.19 - $619.13 $165,960 - $195,645	-316 Reduced 23.58%	1,024 $596,000
Q3 2023 Oct 18, 2023	BUY	$434.7 - $599.3 $255,168 - $351,789	587 Added 77.95%	1,340 $719,000
Q3 2022 Oct 21, 2022	BUY	$296.48 - $337.87 $223,249 - $254,416	753 New	753 $243,000
Q2 2022 Jul 22, 2022	SELL	$278.73 - $327.27 $154,137 - $180,980	-553 Closed	0 $0
Q1 2022 Apr 20, 2022	SELL	$234.69 - $291.66 $12,203 - $15,166	-52 Reduced 8.6%	553 $158,000
Q2 2021 Jul 23, 2021	SELL	$180.55 - $233.54 $14,082 - $18,216	-78 Reduced 11.42%	605 $139,000
Q1 2021 Apr 20, 2021	BUY	$164.32 - $212.72 $14,788 - $19,144	90 Added 15.18%	683 $128,000
Q3 2019 Oct 11, 2019	SELL	$106.79 - $116.16 $29,367 - $31,944	-275 Reduced 31.68%	593 $66,000
Q1 2019 Apr 17, 2019	SELL	$111.31 - $131.02 $27,716 - $32,623	-249 Reduced 22.29%	868 $113,000
Q4 2018 Jan 18, 2019	BUY	$105.9 - $118.64 $17,685 - $19,812	167 Added 17.58%	1,117 $129,000
Q4 2017 Jan 16, 2018	BUY	$81.94 - $87.89 $24,582 - $26,367	300 Added 46.15%	950 $80,000
Q3 2017 Oct 12, 2017	BUY	$77.07 - $85.54 $50,095 - $55,601	650	650 $56,000

Others Institutions Holding LLY

# of Institutions

3,869

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $876B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gemmer Asset Management LLC with notifications on news.

Account

Gemmer Asset Management LLC Eli Lilly & CO Transaction History